Old Web
English
Sign In
Acemap
>
authorDetail
>
Shuji Tsukiyama
Shuji Tsukiyama
Daiichi Sankyo
Internal medicine
Medicine
Prasugrel
Percutaneous coronary intervention
Clopidogrel
3
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy.
2021
Cardiovascular Intervention and Therapeutics
Ping-Yen Liu
Cheng-Huang Su
Feng-Yu Kuo
Wen-Lieng Lee
Yi-Chih Wang
Wei-Shiang Lin
Pao-Hsien Chu
Tse-Min Lu
Ping-Han Lo
Cheng-Han Lee
Wei-Ren Lan
Chien-Lung Huang
Shuji Tsukiyama
Wei-Chen Yang
Li-Chung Cheng
Virginia Rafael
Christian Nikolajsen
Wei-Hsian Yin
Show All
Source
Cite
Save
Citations (0)
Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy (Cardiovascular Intervention and Therapeutics, (2021), 10.1007/s12928-021-00771-w)
2021
Cardiovascular Intervention and Therapeutics
Ping-Yen Liu
Cheng-Huang Su
Feng-Yu Kuo
Wen-Lieng Lee
Yi-Chih Wang
Wei-Shiang Lin
Pao-Hsien Chu
Tse-Min Lu
Ping-Han Lo
Cheng-Han Lee
Wei-Ren Lan
Chien-Lung Huang
Shuji Tsukiyama
Wei-Chen Yang
Li-Chung Cheng
Virginia Rafael
Christian Nikolajsen
Wei-Hsian Yin
Show All
Source
Cite
Save
Citations (0)
Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study
2017
BMJ open diabetes research & care
Nobuya Inagaki
Hubert S. Chou
Shuji Tsukiyama
Takuo Washio
Kazuhito Shiosakai
Yasuhiko Nakatsuka
Takashi Taguchi
Show All
Source
Cite
Save
Citations (13)
1